Zobrazeno 1 - 10
of 5 484
pro vyhledávání: '"Michor, F."'
Autor:
Cheng YC; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA 02215.; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA 02215.; Center for Cancer Evolution, Dana-Farber Cancer Institute, Boston, MA 02215.; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138., Zhang Y; State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China., Tripathi S; Yale Center for Systems and Engineering Immunology and Department of Immunobiology, Yale School of Medicine, New Haven, CT 06510., Harshavardhan BV; Interdisciplinary Mathematics Initiative, Indian Institute of Science, Bangalore 560012, India., Jolly MK; Centre for BioSystems Science and Engineering, Indian Institute of Science, Bangalore 560012, India., Schiebinger G; Department of Mathematics, University of British Columbia, Vancouver, BC V6T 1Z2, Canada., Levine H; Center for Theoretical Biological Physics, Northeastern University, Boston, MA 02115.; Department of Physics, Northeastern University, Boston, MA 02115., McDonald TO; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA 02215.; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA 02215.; Center for Cancer Evolution, Dana-Farber Cancer Institute, Boston, MA 02215.; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138., Michor F; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA 02215.; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA 02215.; Center for Cancer Evolution, Dana-Farber Cancer Institute, Boston, MA 02215.; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138.; The Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02138.; The Ludwig Center at Harvard, Boston, MA 02115.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2024 Aug 06; Vol. 121 (32), pp. e2406842121. Date of Electronic Publication: 2024 Aug 02.
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2024 Jun 29. Date of Electronic Publication: 2024 Jun 29.
Autor:
Riviere-Cazaux C, Graser CJ, Warrington AE, Hoplin MD, Andersen KM, Malik N, Palmer EA, Carlstrom LP, Dasari S, Munoz-Casabella A, Ikram S, Ghadimi K, Himes BT, Jusue-Torres I, Sarkaria JN, Meyer FB, Van Gompel JJ, Kizilbash SH, Sener U, Michor F, Campian JL, Parney IF, Burns TC
Publikováno v:
MedRxiv : the preprint server for health sciences [medRxiv] 2024 May 16. Date of Electronic Publication: 2024 May 16.
Autor:
Janiszewska M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Department of Molecular Medicine, The Scripps Research Institute, Jupiter, FL, USA., Tabassum DP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Research Square, Durham, NC, USA., Castaño Z; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Hematology Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA., Cristea S; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA.; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA., Yamamoto KN; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA.; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA., Kingston NL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Murphy KC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Shu S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Harper NW; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Del Alcazar CG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Alečković M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Ekram MB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; WuXi NextCODE, Cambridge, MA, USA., Cohen O; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; The Eli and Edythe L. Broad Institute of Harvard and MIT, Cambridge, MA, USA., Kwak M; Department of Biomedical Engineering, Yale School of Medicine, New Haven, CT, USA.; Yale Comprehensive Cancer Center, New Haven, CT, USA., Qin Y; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Hematology Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; EdiGene, Cambridge, MA, USA., Laszewski T; Hematology Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA., Luoma A; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, and Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA, USA., Marusyk A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Department of Cancer Imaging and Metabolism, Moffitt Cancer Center, Tampa, FL, USA., Wucherpfennig KW; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, and Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA, USA., Wagle N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; The Eli and Edythe L. Broad Institute of Harvard and MIT, Cambridge, MA, USA., Fan R; Department of Biomedical Engineering, Yale School of Medicine, New Haven, CT, USA.; Yale Comprehensive Cancer Center, New Haven, CT, USA., Michor F; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA.; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.; The Eli and Edythe L. Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Center for Cancer Evolution, Dana-Farber Cancer Institute, Boston, MA, USA.; Ludwig Center at Harvard, Boston, MA, USA., McAllister SS; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Hematology Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; The Eli and Edythe L. Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Harvard Stem Cell Institute, Cambridge, MA, USA., Polyak K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. kornelia_polyak@dfci.harvard.edu.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. kornelia_polyak@dfci.harvard.edu.; Department of Medicine, Harvard Medical School, Boston, MA, USA. kornelia_polyak@dfci.harvard.edu.; The Eli and Edythe L. Broad Institute of Harvard and MIT, Cambridge, MA, USA. kornelia_polyak@dfci.harvard.edu.; Center for Cancer Evolution, Dana-Farber Cancer Institute, Boston, MA, USA. kornelia_polyak@dfci.harvard.edu.; Ludwig Center at Harvard, Boston, MA, USA. kornelia_polyak@dfci.harvard.edu.; Harvard Stem Cell Institute, Cambridge, MA, USA. kornelia_polyak@dfci.harvard.edu.
Publikováno v:
Nature cell biology [Nat Cell Biol] 2024 May; Vol. 26 (5), pp. 841.
Publikováno v:
In Annals of Oncology January 2018 29(1):264-270
Autor:
Yu, H.A. *, Sima, C., Feldman, D., Liu, L.L., Vaitheesvaran, B., Cross, J., Rudin, C.M., Kris, M.G., Pao, W., Michor, F., Riely, G.J.
Publikováno v:
In Annals of Oncology February 2017 28(2):278-284
Autor:
Parra ER; Departments of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Zhang J; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Duose DY; Departments of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Gonzalez-Kozlova E; Department of Oncological Sciences, Mount Sinai, New York, New York.; Tisch Cancer Institute, Mount Sinai, New York, New York.; Precision Immunology Institute, Mount Sinai, New York, New York.; Icahn School of Medicine at Mount Sinai, New York, New York., Redman MW; SWOG Statistical Center, Fred Hutchinson Cancer Center, Seattle, Washington., Chen H; Department of Thoracic-Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Manyam GC; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kumar G; Departments of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Zhang J; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Song X; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Lazcano R; Departments of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Marques-Piubelli ML; Departments of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Laberiano-Fernandez C; Departments of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Rojas F; Departments of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Zhang B; Departments of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Taing L; CIMAC-CIDC Network, Pipeline Development and Portal Integration, Dana-Farber Cancer Institute, Boston, Massachusetts., Jhaveri A; CIMAC-CIDC Network, Pipeline Development and Portal Integration, Dana-Farber Cancer Institute, Boston, Massachusetts., Geisberg J; CIMAC-CIDC Network, Pipeline Development and Portal Integration, Dana-Farber Cancer Institute, Boston, Massachusetts., Altreuter J; CIMAC-CIDC Network, Pipeline Development and Portal Integration, Dana-Farber Cancer Institute, Boston, Massachusetts., Michor F; CIMAC-CIDC Network, Pipeline Development and Portal Integration, Dana-Farber Cancer Institute, Boston, Massachusetts., Provencher J; CIMAC-CIDC Network, Pipeline Development and Portal Integration, Dana-Farber Cancer Institute, Boston, Massachusetts., Yu J; CIMAC-CIDC Network, Pipeline Development and Portal Integration, Dana-Farber Cancer Institute, Boston, Massachusetts., Cerami E; CIMAC-CIDC Network, Pipeline Development and Portal Integration, Dana-Farber Cancer Institute, Boston, Massachusetts., Moravec R; Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, NCI, Bethesda, Maryland., Kannan K; Departments of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Luthra R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Alatrash G; Department of Stem Cell Transplantation, The University of Texas MD Anderson Cancer, Houston, Texas., Huang HH; Precision Immunology Institute, Mount Sinai, New York, New York.; Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York., Xie H; Precision Immunology Institute, Mount Sinai, New York, New York., Patel M; Precision Immunology Institute, Mount Sinai, New York, New York., Nie K; Precision Immunology Institute, Mount Sinai, New York, New York., Harris J; Precision Immunology Institute, Mount Sinai, New York, New York., Argueta K; Precision Immunology Institute, Mount Sinai, New York, New York., Lindsay J; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Biswas R; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Van Nostrand S; CIMAC-CIDC Network, Pipeline Development and Portal Integration, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Kim-Schulze S; Department of Oncological Sciences, Mount Sinai, New York, New York.; Tisch Cancer Institute, Mount Sinai, New York, New York.; Precision Immunology Institute, Mount Sinai, New York, New York.; Icahn School of Medicine at Mount Sinai, New York, New York., Gray JE; Moffitt Cancer Caner, Tampa, Florida., Herbst RS; Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut., Wistuba II; Departments of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Gettinger S; Moffitt Cancer Caner, Tampa, Florida., Kelly K; International Association for the Study of Lung Cancer, Denver, Colorado., Bazhenova L; University of California San Diego Moores Cancer Center, La Jolla, California., Gnjatic S; Department of Oncological Sciences, Mount Sinai, New York, New York.; Tisch Cancer Institute, Mount Sinai, New York, New York.; Precision Immunology Institute, Mount Sinai, New York, New York.; Icahn School of Medicine at Mount Sinai, New York, New York., Lee JJ; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Zhang J; Department of Thoracic-Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Haymaker C; Departments of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Apr 15; Vol. 30 (8), pp. 1655-1668.
Autor:
Landshammer, A., https://orcid.org/0000-0001-5367-3303, Bolondi, A., https://orcid.org/0000-0002-1096-9435, Kretzmer, H., https://orcid.org/0000-0002-0723-4980, Much, C., Buschow, R., https://orcid.org/0000-0002-9800-2578, Rose, A., Wu, H., Mackowiak, S., Braendl, B., Gießelmann, P., https://orcid.org/0000-0002-1227-897X, Tornisiello, R., https://orcid.org/0000-0002-6358-4934, Mohan Parsi, K., Huey, J., Mielke, T., https://orcid.org/0000-0001-9275-3146, Meierhofer, D., https://orcid.org/0000-0002-0170-868X, Maehr, R., Hnisz, D., https://orcid.org/0000-0002-6256-1693, Michor, F., Rinn, J., Meissner, A., https://orcid.org/0000-0001-8646-7469
Publikováno v:
eLife
Long non-coding RNAs (lncRNAs) have emerged as fundamental regulators in various biological processes, including embryonic development and cellular differentiation. Despite much progress over the past decade, the genome-wide annotation of lncRNAs rem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1874::bae6a3afcdb7a75518b6bcfd4c703fd8
https://hdl.handle.net/21.11116/0000-000C-9E59-F21.11116/0000-000C-9E5B-D
https://hdl.handle.net/21.11116/0000-000C-9E59-F21.11116/0000-000C-9E5B-D
Autor:
Liu Y; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA 02115, USA., Altreuter J; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA 02115, USA., Bodapati S; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA 02115, USA., Cristea S; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA., Wong CJ; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Biomedical Informatics, Harvard Medical School, Boston, MA 20115, USA., Wu CJ; Harvard Medical School, Boston, MA 02115, USA; The Eli and Edythe Broad Institute of MIT and Harvard, Cambridge, MA 02139, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA., Michor F; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA; Department of Biomedical Informatics, Harvard Medical School, Boston, MA 20115, USA; The Eli and Edythe Broad Institute of MIT and Harvard, Cambridge, MA 02139, USA; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA; Center for Cancer Evolution, Dana-Farber Cancer Institute, Boston, MA 02138, USA; The Ludwig Center at Harvard, Boston, MA 02115, USA. Electronic address: michor@jimmy.harvard.edu.
Publikováno v:
Cell genomics [Cell Genom] 2024 Jan 10; Vol. 4 (1), pp. 100444. Date of Electronic Publication: 2023 Nov 21.
Autor:
Kaczanowska S; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Murty T; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Alimadadi A; La Jolla Institute for Immunology, La Jolla, CA, USA; Immunology Center of Georgia, Augusta University, Augusta, GA, USA; Georgia Cancer Center, Medical College of Georgia at Augusta University, Augusta, GA, USA., Contreras CF; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA; Department of Oncology, University of Oxford, Oxford, UK., Duault C; Stanford Human Immune Monitoring Center, Stanford University School of Medicine, Stanford, CA, USA., Subrahmanyam PB; Stanford Human Immune Monitoring Center, Stanford University School of Medicine, Stanford, CA, USA., Reynolds W; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Gutierrez NA; La Jolla Institute for Immunology, La Jolla, CA, USA., Baskar R; Department of Pathology, Stanford University, Stanford, CA, USA., Wu CJ; Broad Institute, Cambridge, MA, USA; Dana-Farber Cancer Institute, Boston, MA, USA., Michor F; Broad Institute, Cambridge, MA, USA., Altreuter J; Broad Institute, Cambridge, MA, USA., Liu Y; Broad Institute, Cambridge, MA, USA., Jhaveri A; Broad Institute, Cambridge, MA, USA., Duong V; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Anbunathan H; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Ong C; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Zhang H; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Moravec R; Cancer Therapy Evaluation Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Yu J; Dana-Farber Cancer Institute, Boston, MA, USA., Biswas R; Dana-Farber Cancer Institute, Boston, MA, USA., Van Nostrand S; Dana-Farber Cancer Institute, Boston, MA, USA., Lindsay J; Dana-Farber Cancer Institute, Boston, MA, USA., Pichavant M; Immunology Center of Georgia, Augusta University, Augusta, GA, USA., Sotillo E; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Bernstein D; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Carbonell A; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Derdak J; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Klicka-Skeels J; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Segal JE; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Dombi E; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Harmon SA; Artificial Intelligence Resource, Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Turkbey B; Artificial Intelligence Resource, Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Sahaf B; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Bendall S; Georgia Cancer Center, Medical College of Georgia at Augusta University, Augusta, GA, USA., Maecker H; Immunology Center of Georgia, Augusta University, Augusta, GA, USA., Highfill SL; Center for Cellular Engineering, Department of Transfusion Medicine, National Institutes of Health Clinical Center, Bethesda, MD, USA., Stroncek D; Center for Cellular Engineering, Department of Transfusion Medicine, National Institutes of Health Clinical Center, Bethesda, MD, USA., Glod J; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Merchant M; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Hedrick CC; La Jolla Institute for Immunology, La Jolla, CA, USA; Immunology Center of Georgia, Augusta University, Augusta, GA, USA; Georgia Cancer Center, Medical College of Georgia at Augusta University, Augusta, GA, USA., Mackall CL; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Ramakrishna S; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA. Electronic address: ramakrs@stanford.edu., Kaplan RN; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Electronic address: rosie.kaplan@nih.gov.
Publikováno v:
Cancer cell [Cancer Cell] 2024 Jan 08; Vol. 42 (1), pp. 35-51.e8. Date of Electronic Publication: 2023 Dec 21.